Key result
Low-dose prednisolone linked to ~26% lower serum creatinine in CCE-related acute renal failure.
Why the study?
The prognosis of renal cholesterol crystal embolism is poor and no optimal therapy has been established for CCE-related acute renal failure.
Does low-dose prednisolone improve acute renal failure in patients with cholesterol crystal embolism?
Observational (n=7)
Does low-dose prednisolone improve acute renal failure in patients with cholesterol crystal embolism?
Low-dose prednisolone may ameliorate acute renal failure caused by cholesterol crystal embolism, likely by reducing the inflammatory reaction surrounding affected renal vessels.
Answers are grounded in this paper and cite their sources.
Low-dose prednisolone in CCE-related ARF remains hypothesis-generating; randomized trials needed before any practice change.
AIMS: The prognosis of renal cholesterol crystal embolism (CCE) is poor. Although various treatments for CCE have been attempted, there is no optimal therapy. We tested the effect of low-dose prednisolone (PS) on CCE-related acute renal failure (ARF). PATIENTS AND METHODS: 7 patients (mean age 69 years) diagnosed with CCE-related ARF were treated with oral PS at 15-20 mg/day for 2-4 weeks, which was then tapered at 5 mg/day over 2-4 weeks, followed by 5 mg/day maintenance dose. Recurrent ARF during PS tapering was treated with a larger dose of PS. RESULTS: Inciting factors were identified in four patients: coronary angiography (n=3) and cerebral angiography (n=1). On admission, serum creatinine (SCr) was 2.1 +/- 0.3 mg/dl (mean +/- SEM). SCr and eosinophil count before treatment were 4.2 +/- 0.4 mg/dl and 682 +/- 73/microl, respectively. PS therapy improved ARF in all cases at week 2 (SCr 3.8 +/- 0.5 mg/dl) parallel to a decrease in eosinophilia (116 +/- 30/microl), and at week 4 (3.1 +/- 0.4 mg/dl and 134 +/- 20/microl, respectively). At last follow-up, renal function was improved or maintained in 5 patients compared with that at week 4 post-treatment. One patient died of lung cancer. Another required LDL apheresis and hemodialysis but died due to CCE-related multi-organ failure. A third patient had recurrent ARF and was re-treated with a larger dose of PS, which resulted in an immediate decrease in SCr. However, the patient developed acute renal dysfunction due to congestive heart failure, and required hemodialysis. CONCLUSIONS: Low-dose PS improved CCE-related ARF, probably through amelioration of inflammatory reaction surrounding affected renal vessels.
No takes yet. Share an insight, caveat, or question.
Nakayama et al. (2006) conducted an observational in Cholesterol crystal embolism (CCE)-related acute renal failure (n=7). Low-dose prednisolone was evaluated on Serum creatinine and eosinophil count. Low-dose prednisolone improved CCE-related acute renal failure, reducing mean serum creatinine from /dl before treatment to /dl at 4 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: